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The endophenotype concept was initially proposed to enhance the power of genetic studies of complex disorders. It is closely 
related to the genetic component in a liability-threshold model; a perfect endophenotype should have a correlation of 1 with the 
genetic component of the liability to disease. In reality, a putative endophenotype is unlikely to be a perfect representation of the 
genetic component of disease liability. The magnitude of the correlation between a putative endophenotype and the genetic com-
ponent of disease liability can be estimated by fitting multivariate genetic models to twin data. A number of statistical methods 
have been developed for incorporating endophenotypes in genetic linkage and association analyses with the aim of improving 
statistical power. The most recent of such methods can handle multiple endophenotypes simultaneously for the greatest increase in 
power. In addition to increasing statistical power, endophenotype research plays an important role in helping to understand the 
mechanisms which connect the associated genetic variants with disease occurrence. Novel statistical approaches may be required 
for the analysis of the complex relationships between endophenotypes at different levels and how they converge to cause the oc-
currence of disease. 
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Most common human diseases, such as coronary heart dis-
ease, diabetes, cancers, bipolar affective disorders and 
schizophrenia, have complex aetiology. While they tend to 
cluster in families, they do not exhibit the characteristic 
Mendelian segregation ratios of single-gene disorders. These 
diseases therefore cannot be solely caused by a single ge-
netic mutation, but have a more complex genetic architec-
ture. Over the last 3 decades, various genetic approaches, 
starting with linkage scans, followed by candidate gene and 
targeted association studies, and most recently genome- 
wide association studies (GWAS), have been used to iden-
tify and characterize the genetic loci for such complex dis-
eases. While many susceptibility loci have been identified, 
the vast majority of these loci have very small effects on 
disease risk, typically with odds ratios under 1.5. Even in 
aggregate, the loci so far identified fall far short of being 
able to explain the level of familial clustering observed for 
the diseases. This appears to be especially the case for psy-
chiatric disorders such as schizophrenia, bipolar affective 
disorder and unipolar depression. 
The endophenotype strategy has been proposed as a way 
to improve the statistical power of genetic studies (e.g., [1]). 
An endophenotype is a quantitative phenotype which 
measures some neurobiological mechanisms in the path-
ways from genotype to phenotype. The criteria for an en-
dophenotype include four elements: (a) the presence of a 
correlation between the disease and putative endophenotype 
in the same individual, (b) evidence that the putative endo-
phenotype precedes the disease and is therefore likely to be 
a cause rather than a consequence of the disease, (c) evi-
dence that the correlation between the disease and the puta-
tive endophenotype occurs at the familial as well as the  
individual level, and (d) evidence that this familial correlation 
is at least partially explained by genes that have an influence 
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on both disease risk and the putative endophenotype.  
Although the concept of endophenotype was introduced 
for psychiatric disorders (e.g., [2]), it is also applicable to 
medical conditions. For instance, blood pressure and blood 
sugar levels can be considered as endophenotypes for hy-
pertension and diabetes, respectively. 
1  Statistical properties of a perfect  
endophenotype 
Under the liability-threshold model, susceptibility to disease 
is a normally distributed variable in the population, but is 
not directly measured. Under this model, individuals whose 
liability exceeds a certain threshold value develop the dis-
ease. For multifactorial diseases, heritability refers to the 
proportion of variance in liability explained by genetic fac-
tors. Heritability estimation therefore explicitly assumes a 
liability-threshold model. 
Under a liability-threshold model, the perfect endophe-
notype for a disease is a trait that is perfectly correlated to 
the genetic component of liability. Assuming both the ge-
netic and environmental components of liability to be nor-
mally distributed and independent, a perfect endophenotype 
should also be normally distributed, and have an average 
deviation from the population mean (in standard deviation 
units) in affected individuals of  
 
1( ( )) ,
 h KD
K
 (1) 
where K is the population frequency of the disease, h is the 
square root of the heritability of the disease,  is the stand-
ard normal density function and –1 is the inverse standard 
normal distribution function. For first-degree relatives of 
affected individuals, the expected deviation of the endo-
phenotype from the population mean is D/2 standard devia-
tion units. For example, for a disease with population fre-
quency of 1% and heritability of 0.8, the average deviation 
of a perfect endophenotype would be 2.38 standard devia-
tion units, while for first-degree relatives would be 1.19 
standard deviation units. 
Having a perfect endophenotype can lead to substantial 
power increases in genetic association studies. For example, 
in a simple case-control study, for a disease with K=0.01, a 
risk allele with frequency 0.3 and allelic odds ratio 1.2 act-
ing in a multiplicative fashion, the required sample size for 
80% power is 5376 cases and equal number of controls, for 
the genome-wide significance level of 5×10–8 (Genetic 
Power Calculator [3], http://pngu.mgh.harvard.edu/~purcell/ 
gpc/qcc.html). If, however, the controls are selected to be 
below the population average in endophenotype value, then 
the sample size required will be reduced to 3265 cases and 
3265 controls. If the controls are selected to be from the 
opposite extreme 1% of the endophenotype distribution, 
then the required sample size will be reduced further to 
1414 cases and 1414 controls. 
2  Modelling disease-endophenotype  
relationships 
The classical twin design is one of the most powerful study 
designs for estimating the relative contribution of genetic 
and environmental factors to human traits or diseases [4,5]. 
The classical twin study consists of a design in which data 
are collected from identical or monozygotic (MZ) twins and 
fraternal or dizygotic (DZ) twins reared together in the same 
environment. Based on quantitative genetic theory, a phe-
notype (an observed trait) can be partly a result of genetic 
factors (G) and partly influenced by environmental factors. 
There are two sources of environmental variances: common 
environmental variance (C) and individual-specific envi-
ronmental variance (E). C is due to the shared environment 
within the family members. E results from influences that 
are unique to a person, and often also includes measurement 
error. The total phenotypic variance of a trait is the sum of 
all three sources of variances, G+C+E [6]. If we assume that 
the effect of shared environment impacts MZ and DZ twin 
pairs equally, then the difference in covariance between MZ 
twins, who share all genes, and DZ twins, who share half 
their genes on average, indicates the extent to which genetic 
factors influence the trait. Heritability (h2) is the proportion of 
the total phenotypic variance explained by genetic factors [6].  
When multiple traits (such as a disease and a putative 
endophenotype) are collected in the same MZ and DZ twin 
pairs, it is possible not only to estimate the heritability of 
each trait but also to address questions such as whether the 
same set of genes accounts for variation in more than one 
phenotype. And if so, to what extent do the same genes ex-
plain the covariation between the phenotypes? 
In the multivariate twin analysis, the focus is on the co-
variance between traits across twins rather than the variance 
of each trait considered separately [7]. Consider two phe-
notypes, schizophrenia and sensory gating event related 
potential (ERP), for example. MZ and DZ correlations are 
compared across the two traits; that is, twin one’s affection 
status for schizophrenia is correlated with the co-twin’s 
sensory gating ERP score. If the overall cross-twin cross- 
trait correlations are greater for MZ than for DZ twins, this 
suggests a genetic overlap between the two traits. If the 
cross-twin cross-trait correlations are the same and greater 
than zero for MZ and DZ pairs, it indicates only shared 
common environmental (C) influences contributing to the 
correlation. If the cross-twin cross-trait correlations are 
non-significant for both MZ and DZ pairs, but there is a 
significant phenotypic correlation between schizophrenia 
and sensory gating ERP score, it indicates the effects of 
specific environment (E) on the observed phenotypic corre- 
lation.   
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Figure 1  Modelling disease-endophenotype relationships ― path diagram for bivariate model.  
The genetic correlation (Rg) for a bivariate model, as  
illustrated in Figure 1, is derived as the genetic covariance 
between trait 1 (i.e., schizophrenia) and 2 (i.e., sensory gat-
ing ERP), given as a11a21, divided by the square root of the 
product of the genetic variances of trait 1 (a11
2) and 2 (a21
2 + 
a22
2):  
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Similarly, the common (Rc) and specific (Re) environ-
mental correlations between schizophrenia and sensory gat-
ing ERP are derived as the C and E covariances between 
trait 1 and 2 divided by the square root of the products of 
the C and E variances of trait 1 and 2, respectively:  
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The phenotypic correlation, Rph, is the sum of the prod-
uct of the genetic correlation and the heritabilities of the two 
phenotypes, the product of the c correlation and the c effects 
of the two phenotypes, and the product of the e correlation 
and the e effects of the two phenotypes:  
 2 2 2ph trait1 trait 2 trait1gR h R h c     
 2 2 2trait 2 trait1 trait 2 .c eR c e R e      (5) 
If the genetic correlation is 1, schizophrenia and sensory 
gating ERP share completely overlapping genetic influences. 
If the genetic correlation is less than 1, at least some genes 
are specific to only one trait. A large genetic correlation, 
however, does not imply a large phenotypic correlation, as 
the latter is also a function of the heritabilities. If these are 
low, the genetic contribution to the observed correlation 
will also be low. 
The twin design, when augmented by sophisticated 
structural equation modeling (SEM) techniques and multi-
variate analyses, thus allows for the simultaneous modeling 
of diseases and endophenotypes to determine their common 
genetic aetiology. The power to detect disease risk genes 
will only be increased through the use of endophenotypes if 
their association is due to pleiotropic genetic effects [8]. 
When studying rare diseases such as schizophrenia 
(SCZ), it is often a more efficient strategy to collect data 
from selected samples (e.g., through affected probands). 
Modelling disease-endophenotype relationships in selected 
samples requires an ascertainment correction. This means 
that the fit function used in the SEM has to be corrected for 
the proportion of the population that is not observed. One 
method for correcting incomplete ascertainment is by in-
troducing an ascertainment probability for each cell (values 
between 0 and 1) and multiplying the cell probabilities with 
these ascertainment probabilities in a user defined fit-  
function [9]. An alternative way is by fixing the model pa-
rameters for the selection variable (i.e., disease status) [10].  
An example of modeling disease-endophenotype rela-
tionship can be found in the Maudsley Schizophrenia Twin 
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Study [11]. This study involved a sample of concordant MZ 
SCZ twins, discordant MZ SCZ twins, and healthy MZ and 
DZ twin pairs. Data on three putative neurophysiological 
endophenotypes were collected (Sensory gating ERP, P300 
ERPs, and mismatch negativity [MMN]). SEM analyses 
were applied to: (a) estimate the heritability of each ERP 
index, (b) quantify the relationship between each ERP phe-
notype and SCZ, and (c) test the significance of partitioned 
genetic and environmental correlations with the illness. The 
results indicated that all three ERP phenotypes are heritable 
traits. Also, significant phenotypic correlations were found 
between SCZ and each ERP phenotype; i.e., SCZ was sig-
nificantly associated with smaller P300 amplitude (rph = 
–0.35; 95% CI = –0.50 to –0.19), decreased sensory gating 
(rph = 0.40; 95% CI = 0.24 to 0.53), and reduced MMN (rph 
= 0.31; 95% CI = 0.15 to 0.46). Further, the main source of 
the observed phenotypic association was due to significant 
genetic correlations. Sensory gating had the highest genetic 
correlations with SCZ (Rg = 0.59), followed by the P300 
amplitude (Rg = –0.48), suggesting that these measures are 
valid SCZ endophenotypes. MMN, on the other hand, had 
the lowest genetic correlation (Rg = 0.31) [11]. 
3  Incorporating endophenotypes into linkage 
and association analyses to increase power 
Typical linkage studies of complex disease have generally 
relied on the use of affected sibling pairs. The methodology 
relies on the measurement of allelic sharing identical by 
descent (ibd). On average, siblings share 50% of their 
chromosomal material ibd. If a disease-causing locus is 
present, sharing will increase above 50% at that particular 
location in the genome. Conversely, a pair of sibs who are 
discordant for the disease will share less than 50% at a dis-
ease locus. If a common disease is present in 10% of the 
population, under the liability threshold model, we know 
that those affected score somewhere in the top 10% of the 
liability distribution. Those who are not affected score 
somewhere in the bottom 90% of this liability distribution. 
Given that, it is obvious that affected sibling pairs could be 
highly informative, as both score in the extreme of the lia-
bility distribution. However, a discordant pair is a lot less 
informative, since the unaffected member can score almost 
anywhere on the unmeasured liability (the bottom 90%). 
However, the use of an endophenotype which is a quan-
titative trait and highly correlated with disease status allows 
a much more precise estimate of both an affected and an 
unaffected individual’s liability score. If we have a proxy 
for liability in the quantitative endophenotype, instead of 
ascertaining a sample of simply concordant and discordant 
sibling pairs, we can select for extreme concordance and 
extreme discordance. Instead of selecting individuals in the 
bottom 90% of the liability distribution, for example, we 
can consider only those who score in the bottom 10% as 
unaffected. Furthermore, having available meaningful quan-
titative data on both cases and controls, and using analysis 
methods which make use of quantitative data, further in-
creases power over using simple affection status. 
An example of the use of endophenotypes in linkage 
analysis to ascertain sib pairs who are both extremely con-
cordant and extremely discordant is the large popula-
tion-based sample of sibships assessed for anxiety and de-
pression measures in the GENESiS study [12]. This study 
involved collection of questionnaire data on a large com-
munity-based sample of 34,371 people, of which 14,807 
were members of sibships of sizes 2–7, with the majority 
sib pairs. These questionnaires comprised several well-  
validated instruments for assessing anxiety and depression 
symptoms, personality traits, and psychological distress. 
Using an algorithm implemented in the SEL (SELection for 
QTL Linkage) program [13], the goal was to obtain DNA 
samples from the most informative 10% of all sibships, 
based on their composite phenotypic scores across four 
questionnaire-based assessments. Informativeness was then 
recalculated on the 65% of samples who returned DNA and 
another round of selection was performed to choose those to 
be genotyped on 400 microsatellite markers, for subsequent 
quantitative trait linkage analysis. Sibships which are most 
discordant or extreme concordant on the phenotype are the 
most informative, with their informativeness a function of 
the sibling correlation on the phenotype. The SEL program 
ranks the sibships based on their likely contribution to the 
noncentrality parameter for linkage, using only phenotypic 
information. Given that this was a selected sample, it was 
ideally suited for regression-based linkage analysis [14]. 
The study also employed an average of two repeated 
measures of the Eysenck personality questionnaire (EPQ-N; 
Eysenck & Eysenck, 1975), measured on two occasions in 
78% of those subjects genotyped, rather than just a single 
measurement occasion, reducing measurement error and 
thereby increasing heritability [6] and power. Merlin-   
regress was extended to make use of this additional infor-
mation, allowing the use of averaged phenotypes from any 
number of measurement occasions on a per-subject basis, 
with the method taking account of the differing expected 
error variance on a per-subject basis (see Appendix in [12]). 
This analysis resulted in a LOD of nearly 3 on Chromosome 
6 for the EPQ-N. This study further refined the analysis by 
examining males and females separately, yielding a some-
what higher LOD score [12]. Through the use of endophe-
notypes, rather than simple binary measures of depressed vs. 
not depressed, power was increased by discriminating and 
selecting unaffected people as controls who, in fact, were 
the least neurotic, an endophenotype underlying depression. 
This is a superior approach to using controls who are simply 
not depressed, which would be a very heterogeneous group 
including people who range from borderline depressed to 
those lacking any neurotic tendencies completely. 
In the past few years, the field of psychiatric genetics has 
 Sham P C, et al.   Chinese Sci Bull   November (2011) Vol.56 No.32 3407 
moved completely away from genome-wide linkage studies 
to GWAS. However, the same advantages of the use of en-
dophenotypes apply to GWAS. Thus far, there have been 
few GWAS employing endophenotypes (e.g., [15,16]), as 
primary analyses have been for diagnoses of diseases such 
as schizophrenia and bipolar disorder [17–20]. Nonetheless, 
we expect to see secondary analyses of endophenotypes in 
those studies which have collected them. Our present statis-
tical genetic analysis toolset is ready for such analyses in 
GWAS, with software such as Merlin/QTDT [21–23] and 
PLINK [24] capable of handling quantitative traits, both in 
family designs and studies of unrelated individuals. Power 
of such secondary analyses may not be much greater than 
the original studies of the disorder phenotype, however, 
unless supernormal controls are included whose phenotypic 
scores are at the opposite extreme of the distribution than 
those of the cases. 
4  Model with multiple endophenotypes 
For many diseases, investigators routinely measure multiple 
endophenotypes on the same person in addition to clinical 
diagnosis. The strategy of modeling multiple endopheno-
types in genetic linkage or association analyses can identify 
not only trait-specific quantitative trait loci (QTL), but also 
those shared between correlated traits. Studies have shown 
that including multiple endophenotypes that are correlated 
with each other in the genetic analyses can substantially 
increase power [25–28]. At the clinical level, studying mul-
tiple endophenotypes within a patient sample may help 
identify homogeneous subtypes across diagnostic categories 
by classifying patients based on similar functional, neuro-
physiological, or behavior profiles (e.g., deficits in frontal 
working memory, treatment prognosis, medication re-
sponse). These profiles, in turn, can be used in statistical 
analyses to examine pleiotropic effects of a gene. Therefore, 
including multiple correlated phenotypes as well as select-
ing genetically homogenous phenotypes would increase the 
signal to noise ratio in linkage and association studies. An 
efficient multivariate test of association for population- 
based designs has been implemented in PLINK [24]. 
5  Characterization of differential impact of  
contributing variants 
The utility of the disease-endophenotype mapping approach 
can be extended beyond improving statistical power for 
gene identification [29]. An important feature of endophe-
notypes is that the underlying molecular and neurobiology 
can be systematically examined and characterized in hu-
mans and animals [30,31]. Such neurobiological insight 
becomes valuable in molecular genetic studies for dissect-
ing the functional effects of risk genetic variants or for 
identifying biological mechanisms of a disease―that is, 
linking the pathway from genotype to phenotype [29,32]. 
For example, GWAS analyses have revealed that variations 
in the CACNA1C (alpha 1C subunit of the L-type volt-
age-gated calcium channel) gene are associated with sus-
ceptibility to bipolar disorder [BPD], SCZ and major de-
pression [MDD] [33,34]. However, this gene was not pre-
viously a candidate and its role in the neurobiology and 
neurophysiology of BPD, SCZ, or MDD was unclear. Fol-
low-up association studies using various endophenotypes 
found that the risk genotype predicts greater hippocampal 
activity during emotional processing, increased prefrontal 
activity during executive cognition, and increased expres-
sion of mRNA in human brain [35,36]. Also, an animal 
study found that CACNA1C haploinsufficiency modifies a 
number of anxiety and depressive-like behaviors and inter-
acts with sex to influence behavior [37]. Such phenotypic 
dissection of associations found via GWAS will be neces-
sary to gain a true understanding of the effect of all such 
newly identified loci. 
6  Conclusions 
The endophenotype concept was initially proposed to en-
hance the power of genetic studies of complex disorders. It 
is closely related to the genetic component in a liabil-
ity-threshold model; a perfect endophenotype should have a 
correlation of 1 with the genetic component of the liability 
to disease. Whether a putative endophenotype is a perfect 
representation of the genetic component of liability to a 
disease can be gleaned from the average deviations of the 
endophenotype values among affected proband subjects and 
their first-degree relatives, in relation to the prevalence and 
heritability of the disease in the population. Selecting con-
trols to be from the opposite extreme of the endophenotype 
distribution from the cases can substantially improve statis-
tical power of genetic association studies.  
In reality, a putative endophenotype is unlikely to be a 
perfect representation of the genetic component of disease 
liability. The magnitude of the correlation between a puta-
tive endophenotype and the genetic component of disease 
liability can be estimated by fitting multivariate genetic 
models to twin data. Twin modeling can be complicated by 
the ascertainment procedure of the twin sample, but there 
are appropriate statistical methods to allow for this.  
A number of statistical methods have been developed for 
incorporating endophenotypes in genetic linkage and asso-
ciation analyses with the aim of improving statistical power. 
The most recent of such methods can handle multiple en-
dophenotypes simultaneously for the greatest increase in 
power.  
In addition to increasing statistical power, endopheno-
type research plays an important role in helping to under-
stand the mechanisms which connect genetic variants with 
disease occurrence. The causal pathways are likely to be 
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very complicated and involve endophenotypes at multiple 
levels: from RNA expression profiles and patterns of pro-
tein expression, through neuronal and synaptic properties, to 
neurophysiological and neurocognitive function. Novel sta-
tistical approaches may be required for the analysis of the 
complex relationships between endophenotypes at different 
levels, to understand how they converge to cause the occur-
rence of disease. 
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